RedCloud Holdings plc (RCT) is a London-based software company building AI prediction infrastructure for the fast-moving consumer goods trade, connecting brands, distributors and retailers across Argentina, Nigeria, South Africa, Brazil and other emerging markets through its RedAI platform. The company listed on Nasdaq in March 2025.
The shares traded at $0.0318 shortly after 10:30 a.m. Eastern on Monday, down 11.91% from the previous close of $0.0361. The direction is unambiguously lower, and no fresh company-specific disclosure was published before the decline. Market participants are instead pricing the two events scheduled for Tuesday: a 100-to-1 reverse share split at 12:01 a.m. Eastern and the company's oral hearing before a Nasdaq Hearings Panel that same day.
Monday is the last day RCT trades in its current form. Every 100 ordinary shares held at the effective time will be reclassified into one new share, cutting the count from roughly 144.1 million to about 1.4 million, with a new CUSIP and continued trading under the existing symbol. The stated purpose is mechanical: to raise the per-share bid above Nasdaq's $1.00 minimum. Applied to today's price, the ratio implies a post-split level of roughly $3.18, while the company's underlying market value of about $3 million is unchanged.
That arithmetic explains why the final pre-split sessions tend to be noisy. Position unwinding, fractional-share cash-outs and short-term trading around the adjustment are all consistent with the softness seen today, and the stock has already shown outsized pre-split swings, including a 10.75% gain on November 11 and a 41% surge on November 6.
The larger issue is survivability. Nasdaq issued a Staff Delisting Determination on October 13 after the bid stayed below $1.00 for 30 consecutive business days, and RedCloud was not eligible for a second 180-day cure period because it lacks the stockholders' equity required under initial listing standards. An appeal filed on October 14 stayed any suspension, which is why the shares still trade normally. The panel's decision after Tuesday's hearing is not guaranteed to favor the company.
A separate notice received in August flagged non-compliance with the $35 million minimum market value of listed securities requirement, with a cure window running to February 8, 2027. With a market value near $3 million, that deficiency is not addressed by the split itself.
Macro conditions did not help. Small caps and technology shares sold off through the morning, with the Nasdaq-100 down 2.2%, the S&P 500 down 1.3% and the Russell 2000 down 1.0%. Loss-making micro-cap software names with balance-sheet stress typically amplify moves in the underlying indices, and RCT's decline was roughly nine times the Nasdaq-100's drop.
Turnover was modest relative to the frenetic sessions seen earlier in November, when hundreds of millions of shares changed hands on peak days; the opening hour saw well under a million shares trade. Three-month average volume is about 42 million shares, with the 10-day average above 150 million, so today's activity is light and the move is not accompanied by capitulation-style volume.
Technically, the stock remains deep below its 50-day and 200-day moving averages, which sit near $0.12 and $0.47 respectively, and it is holding above the 52-week low of roughly $0.026. Today's range has been narrow, between about $0.0308 and $0.0336, which points to orderly selling rather than a disorderly break.
The score runs from 0 to 100, where 0 means no meaningful news and a move that is normal for the stock, and 100 means transformative news and an extreme, rare price move. RedCloud scores 32 out of 100.
The verified news is moderate in strength: a 100-to-1 reverse split and a Nasdaq listing hearing are material for a company valued near $3 million, but both were disclosed before today and are procedural rather than operating developments. The price move was modest by the stock's own standards, about 1.9 times the typical daily change of roughly 6.4%, and moves of 11.9% or more occurred seven times in the last 60 sessions. Together, moderate news and an unremarkable move produce the score.
Attention shifts immediately to Tuesday, when split-adjusted trading begins and the Hearings Panel meets. The theoretical post-split price sits comfortably above $1.00, but the bid must hold there for an extended stretch to satisfy the listing rule, and panel rulings frequently take weeks.
Fundamentally, the company's last reported results came on September 30 for the first half of 2026, with trailing revenue near $54.6 million against a net loss, thin cash of roughly $0.85 million at the last balance sheet date, a 0.13 current ratio and negative book value. That combination keeps financing and dilution risk high, and any new capital raise would be a central variable. Coverage is sparse and expectations are minimal.
Risks include a denial at the hearing and a move to over-the-counter trading, renewed selling after the split adjustment, and the unresolved market-value deficiency. Upside would require evidence of operating progress, not simply a higher quoted share price.
Tickeron maintains hundreds of AI trading bots covering thousands of tickers, but only the strongest performers under current market conditions earn a place in the curated Trending AI Robots section. The bots differ widely by strategy, timeframe, performance metrics and the symbols they trade, so the selection adapts as volatility and leadership rotate. For investors navigating a tape like this one, reviewing which automated strategies are currently performing can sharpen decision-making. Explore the page to see the live leaders.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where RCT declined for three days, in 89 of 98 cases, the price declined further within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for RCT entered a downward trend on November 10, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where RCT's RSI Oscillator exited the oversold zone, 11 of 13 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 85%.
The Moving Average Convergence Divergence (MACD) for RCT just turned positive on November 09, 2026. Looking at past instances where RCT's MACD turned positive, the stock continued to rise in 14 of 17 cases over the following month. The odds of a continued upward trend are 82%.
Following a +6.18% 3-day Advance, the price is estimated to grow further. Considering data from situations where RCT advanced for three days, in 44 of 58 cases, the price rose further within the following month. The odds of a continued upward trend are 76%.
RCT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron Valuation Rating of 32 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (-1.906). P/E Ratio (0.000) is within average values for comparable stocks, (9.554). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.824). Dividend Yield (0.000) settles around the average of (0.069) among similar stocks. P/S Ratio (0.181) is also within normal values, averaging (70.383).
The Tickeron Price Growth Rating for this company is 98 (best 1 - 100 worst), indicating slightly worse than average price growth. RCT’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 100 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. RCT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry PackagedSoftware